BIONEER CORPORATION

Bioneer's subsidiary AceBiome achieves cumulative sales of KRW 1 trillion with its ‘BNR17’ 

AceBiome, a leading health functional food company and a subsidiary of BIONEER (CEO Myung-Hee Kim), announced today that its BNR17 brand line, based on Korea’s first body fat-reducing functional probiotic Lactobacillus gasseri BNR17, has surpassed KRW 1 trillion in cumulative sales. Since its launch in late 2018, the brand has solidified its leadership in the diet probiotic market through diversified product lines and an omnichannel strategy that has attracted a broad consumer base.

The BNR17 product lineup focuses on two core values: body fat management and gut health. Its flagship offerings include the diet probiotics BNR17, BNR17 Pro, the four-function powder type BNR17 Plus with added vitamin D and zinc, and BNR17 Protein, which combines vitamin D, calcium, and high-protein content for both daily and fitness-focused consumers. The portfolio also includes BNR Queen, designed to support women’s health during menopause, along with exclusive products tailored for various distribution channels, providing consumers with personalized wellness solutions.

At the core of the brand’s growth lies the Korean human breast milk-derived probiotic strain Lactobacillus gasseri BNR17. The strain’s efficacy in reducing body fat and promoting gut health has been clinically validated in human trials and scientifically supported, with more than 1,200 citations in international peer-reviewed journals (SCIE). Based on this robust scientific foundation, BNR17 has been awarded the “Brand of the Year” for four consecutive years in the diet probiotics category, while BNR Queen has received the same honor for three consecutive years in the menopause probiotics category, further strengthening the brand’s leadership.

To celebrate surpassing the KRW 1 trillion milestone, AceBiome will roll out a series of customer appreciation promotions across all online and offline channels starting on October 15. These include special events on its official website (BNRmall.com), exclusive live commerce broadcasts, and collaborations with major retail and TV home shopping partners. Customers can enjoy special discounts, membership benefits, product bundles, and subscription programs designed to enhance both accessibility and engagement—driving new customer acquisition and strengthening brand loyalty.

AceBiome plans to continue its long-term strategy for sustainable growth in both domestic and global markets by enhancing product quality and expanding global communication around the functionality of BNR17. The company will further strengthen its competitiveness across key wellness categories—including body fat management, gut health, women’s health, skin health, and muscle wellness—through ongoing R&D, expanded clinical studies, and strategic partnerships with domestic and international distribution partners.

“Achieving KRW 1 trillion in cumulative sales for the BNR17 brand line is the result of consumer trust in the scientifically proven efficacy of our ingredients and our consistent delivery of measurable results,” said Myung-Hee Kim, CEO of AceBiome. “We will continue to invest in clinical research and R&D while strengthening collaborations with diverse distribution partners to expand our presence in both domestic and global markets.”